Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

TARAL PATEL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1780632828
CMS profile
307930
Location
COLUMBUS, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$145,340.86

320 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Karyopharm Therapeutics Inc. $38,329.79 31
Janssen Biotech, Inc. $22,060.34 43
Pharmacosmos Therapeutics Inc. $17,647.07 22
GlaxoSmithKline, LLC. $11,452.76 10
Incyte Corporation $11,406.98 24
BeiGene USA, Inc. $9,685.23 11
Gilead Sciences, Inc. $7,832.59 16
E.R. Squibb & Sons, L.L.C. $7,303.15 12
PFIZER INC. $3,575.84 8
AstraZeneca Pharmaceuticals LP $3,562.54 23
Johnson & Johnson Health Care Systems Inc. $3,057.77 2
Mirati Therapeutics, Inc. $2,129.62 2
GENZYME CORPORATION $1,791.26 3
Daiichi Sankyo Inc. $1,787.10 7
Eisai Inc. $395.85 9
Novartis Pharmaceuticals Corporation $365.15 19
Janssen Scientific Affairs, LLC $354.72 3
Fennec Pharmaceuticals, Inc. $228.47 2
Rigel Pharmaceuticals, Inc. $209.47 2
Merck Sharp & Dohme LLC $187.10 7
Genentech USA, Inc. $177.96 3
Blueprint Medicines Corporation $175.38 6
Adaptive Biotechnologies Corporation $166.68 2
Regeneron Healthcare Solutions, Inc. $145.99 2
Stemline Therapeutics Inc. $122.39 3
Exelixis Inc. $117.80 1
SOBI, INC $107.62 3
Astellas Pharma US Inc $104.09 5
JAZZ PHARMACEUTICALS INC. $94.80 3
Celgene Corporation $75.23 4
ABBVIE INC. $75.03 3
EMD Serono, Inc. $71.09 4
ARRAY BIOPHARMA INC $68.41 3
SERVIER PHARMACEUTICALS LLC $61.25 3
Takeda Pharmaceuticals U.S.A., Inc. $55.11 2
SpringWorks Therapeutics, Inc. $48.11 2
Genmab U.S., Inc. $36.46 2
Ipsen Biopharmaceuticals, Inc $36.03 2
Amneal Pharmaceuticals LLC $35.83 2
Geron Corporation $33.64 1
TerSera Therapeutics LLC $31.08 1
Alexion Pharmaceuticals, Inc. $23.21 1
Lilly USA, LLC $22.36 1
Eli Lilly and Company $21.04 1
Amgen Inc. $20.50 1
Aveo Pharmaceuticals, Inc. $20.35 1
Sumitomo Pharma America, Inc. $16.86 1
ADC Therapeutics America, Inc. $13.76 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

320 matching records · $145,340.86 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 320 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 320.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $2,854.0012/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101316226 CMS
Eisai Inc. $28.8212/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110784862 CMS
Geron Corporation $33.6412/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261126533270 CMS
Karyopharm Therapeutics Inc. $1,500.0012/18/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261145537657 CMS
Novartis Pharmaceuticals Corporation $6.1212/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087160281 CMS
Stemline Therapeutics Inc. $18.7312/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142965027 CMS
SOBI, INC $41.2712/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141423287 CMS
Merck Sharp & Dohme LLC $10.7912/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141740753 CMS
Novartis Pharmaceuticals Corporation $18.7312/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087160279 CMS
AstraZeneca Pharmaceuticals LP $20.9312/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105767686 CMS
AstraZeneca Pharmaceuticals LP $99.9512/10/2024 Education No dispute reported Delay: No
Change: NEW
06/30/20261155834166 CMS
Incyte Corporation $18.8512/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141250462 CMS
SOBI, INC $36.9412/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141411752 CMS
E.R. Squibb & Sons, L.L.C. $116.9012/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101316228 CMS
JAZZ PHARMACEUTICALS INC. $30.0012/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150231991 CMS
Gilead Sciences, Inc. $12.7512/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133799268 CMS
AstraZeneca Pharmaceuticals LP $20.7312/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105550314 CMS
BeiGene USA, Inc. $12.0612/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120845027 CMS
BeiGene USA, Inc. $3,300.0012/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120845034 CMS
BeiGene USA, Inc. $124.9912/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120845036 CMS
EMD Serono, Inc. $16.2211/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120273396 CMS
Novartis Pharmaceuticals Corporation $19.4511/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087160275 CMS
AstraZeneca Pharmaceuticals LP $129.7911/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105739109 CMS
Daiichi Sankyo Inc. $28.5211/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089467098 CMS
EMD Serono, Inc. $19.1211/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120273672 CMS
Karyopharm Therapeutics Inc. $24.3911/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261145537659 CMS
Fennec Pharmaceuticals, Inc. $211.7011/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186688 CMS
Karyopharm Therapeutics Inc. $32.5811/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261145537653 CMS
Stemline Therapeutics Inc. $85.0511/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142965036 CMS
Pharmacosmos Therapeutics Inc. $59.7011/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261154825005 CMS
GENZYME CORPORATION $49.7311/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139626666 CMS
GENZYME CORPORATION $1,605.0011/15/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139626668 CMS
Karyopharm Therapeutics Inc. $62.3711/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261145537649 CMS
Karyopharm Therapeutics Inc. $123.2911/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261145537655 CMS
Pharmacosmos Therapeutics Inc. $31.2311/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261154825003 CMS
AstraZeneca Pharmaceuticals LP $14.0511/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104516904 CMS
AstraZeneca Pharmaceuticals LP $24.7711/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104557574 CMS
Astellas Pharma US Inc $25.4311/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139440898 CMS
Eisai Inc. $28.7911/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110784860 CMS
Karyopharm Therapeutics Inc. $815.0011/05/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261145537651 CMS
ARRAY BIOPHARMA INC $16.4911/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131247469 CMS
Novartis Pharmaceuticals Corporation $14.8510/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087160191 CMS
E.R. Squibb & Sons, L.L.C. $1.0410/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101316134 CMS
E.R. Squibb & Sons, L.L.C. $13.8810/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101316132 CMS
Merck Sharp & Dohme LLC $32.6610/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141881432 CMS
Gilead Sciences, Inc. $14.0110/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133842066 CMS
E.R. Squibb & Sons, L.L.C. $600.0010/10/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101316234 CMS
SOBI, INC $29.4110/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141428299 CMS
E.R. Squibb & Sons, L.L.C. $2,854.0010/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101316200 CMS
Novartis Pharmaceuticals Corporation $5.5110/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087160177 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $73,840.60 130
PY2020 $83,449.75 100
PY2021 $68,776.97 135
PY2022 $169,945.02 259
PY2023 $183,849.85 352
PY2024 $145,340.86 320
PY2025 $162,884.23 290

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
TARAL PATEL, NPI 1780632828. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1780632828.
APA 7
IndustryPayments. (2026). TARAL PATEL, NPI 1780632828 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1780632828
Bluebook
TARAL PATEL, NPI 1780632828, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1780632828.

Source: Centers for Medicare & Medicaid Services, Open Payments.